Dynavax Technologies Corp (NAS:DVAX)
$ 13 -0.03 (-0.23%) Market Cap: 1.71 Bil Enterprise Value: 1.17 Bil PE Ratio: 100.23 PB Ratio: 2.51 GF Score: 70/100

Q4 2021 Dynavax Technologies Corp Earnings Call Transcript

Feb 28, 2022 / 09:30PM GMT
Release Date Price: $12.26 (-1.76%)
Operator

Good day, ladies and gentlemen, and welcome to the Dynavax Technologies Fourth Quarter and Full Year 2021 Financial Results Call. As a reminder, this conference call is being recorded. (Operator Instructions)

I would now like to turn the call over to Nicole Arndt, Senior Manager, Investor Relations. You may begin.

Nicole Arndt
Dynavax Technologies Corporation - Senior Manager of IR

Thank you. Good afternoon, and welcome to the Dynavax Fourth Quarter and Full Year 2021 Financial Results and Corporate Update Conference Call. In addition to our press release issued today, a supplementary slide presentation that accompanies today's call is available in the Events section of our website.

Before we begin, I advise you that we will be making forward-looking statements today, including, but not limited to, statements regarding potential market sizes, impact of ACIP recommendation, financial guidance and trends and potential future uses of CpG 1018 adjuvant.

These statements involve risks and uncertainties that could cause actual results to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot